Radiation boost may extend life for bladder cancer patients with few remaining tumors

NCT ID NCT04428554

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding focused radiation to standard treatment helps people with metastatic bladder cancer live longer. It includes patients whose cancer has not worsened after initial therapy and who have three or fewer remaining tumors. About 130 participants will be randomly assigned to receive either standard care alone or standard care plus radiation, and will be followed for up to four years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Brest

    RECRUITING

    Brest, France

  • CHU Besançon

    RECRUITING

    Besançon, France

  • Centre Antoine Lacassagne

    RECRUITING

    Nice, France

  • Centre Francois Baclesse

    RECRUITING

    Caen, France

  • Centre Jean Perrin

    WITHDRAWN

    Clermont-Ferrand, France

  • Centre Oscar Lambret

    WITHDRAWN

    Lille, France

  • Clinique Claude Bernard

    RECRUITING

    Albi, France

  • Clinique Pasteur-Lanroze

    RECRUITING

    Brest, France

  • Groupe Hospitalier Paris Saint-Joseph

    NOT_YET_RECRUITING

    Paris, France

  • Groupement de Radiothérapie et d'Oncologie des Pyrénées

    WITHDRAWN

    Pau, France

  • HIA Bégin

    RECRUITING

    Saint-Mandé, France

  • Institut Andrée Dutreix

    RECRUITING

    Dunkirk, France

  • Institut Bergonie

    RECRUITING

    Bordeaux, France

  • Institut Curie

    RECRUITING

    Paris, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, France

  • Institut Paoli-Calmettes

    RECRUITING

    Marseille, France

  • Institut Universitaire du Cancer Toulouse Oncopole

    RECRUITING

    Toulouse, France

  • Institut de Cancerologie Lucien Neuwirth

    NOT_YET_RECRUITING

    Saint-Priest-en-Jarez, France

  • Institut de Cancerologie de L'Ouest

    RECRUITING

    Angers, France

  • Institut de Cancerologie de L'Ouest

    RECRUITING

    Saint-Herblain, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.